Methods for treating pancreatic disorders
AssigneeAllergan Sales, Inc.
InventorStephen Donovan
Life of this patent
Estimating the term…
Abstract
A method for treating a pancreatic disorder by local administration of a neurotoxin, such as a botulinum toxin, into a cholinergic influenced, exocrine pancreas or endocrine pancreas, thereby reducing a secretion from the injected pancreatic tissue and effectively treating the pancreatic disorder.
Claims30
A method for treating a pancreatic disorder, the method comprising the step of local administration of a neurotoxin to an endocrine pancreatic and/or exocrine pancreatic tissue, thereby treating a pancreatic disorder.
A method for treating a pancreatic disorder, the method comprising the step of injecting a therapeutically effective amount of a botulinum toxin into an endocrine pancreatic tissue and/or to an exocrine pancreatic tissue of a human patient, thereby reducing a secretion from a pancreatic cell and treating a pancreatic disorder.
A method for treating a pancreatic disorder of a human patient, the method comprising the step of local administration to a cholinergic influenced pancreatic tissue of a human patient of a therapeutically effective amount of botulinum toxin type A, thereby reducing a cholinergic influenced secretion from the pancreatic tissue and treating the pancreatic disorder.
A method for treating hypoglycemic hyperinsulinism, the method comprising the step of injecting a cholinergic nervous system influenced pancreatic tissue of a human patient with a therapeutically effective amount of botulinum toxin type A, thereby reducing a cholinergic influenced insulin secretion from the pancreatic tissue and treating hypoglycemic hyperinsulinism.
A method for treating hyperglycemic hyperglucagonism, the method comprising the step of injecting a cholinergic nervous system influenced pancreatic tissue of a human patient with a therapeutically effective amount of botulinum toxin type A, thereby reducing a cholinergic influenced glucagon secretion from the pancreatic tissue and treating hyperglycemic hyperglucagonism.
A method for treating pain associated with pancreatitis, the method comprising the step of local administration of a botulinum toxin to an endocrine pancreatic tissue and/or to an exocrine pancreatic tissue of a patient, thereby reducing pain associated with pancreatitis.
A method for improving patient function, the method comprising the step of local administration of a botulinum toxin to the endocrine and/or exocrine pancreatic tissue of a human patient, thereby improving patient function as determined by improvement in one or more of the factors of reduced pain, reduced time spent in bed, improved healing, and increased ambulation.
Dependencies are inferred from the claim text.